Skip to search boxSkip to navigationSkip to main content

Launching a salt substitute to reduce blood pressure at the population level: A cluster randomized stepped wedge trial in Peru

Research Output: Contribution to journal Article Peer-review

Open access

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Article number

93

Journal (Volume, Issue Number)

Trials (Volume 15, Issue 1)

Publication milestones

  • Published - 25/03/2014

Publication status

Published - 25/03/2014

Publication IDs

  • Scopus: 84897479553
  • PubMed: 24667035

Abstract

Background: Controlling hypertension rates and maintaining normal blood pressure, particularly in resource-constrained settings, represent ongoing challenges of effective and affordable implementation in health care. One of the strategies being largely advocated to improve high blood pressure calls for salt reduction strategies. This study aims to estimate the impact of a population-level intervention based on sodium reduction and potassium increase - in practice, introducing a low-sodium, high-potassium salt substitute - on adult blood pressure levels.Methods/Design: The proposed implementation research study includes two components: Phase 1, an exploratory component, and Phase 2, an intervention component. The exploratory component involves a triangle taste test and a formative research study designed to gain an understanding of the best implementation methods. Phase 2 involves a pragmatic stepped wedge trial design where the intervention will be progressively implemented in several clusters starting the intervention randomly at different times. In addition, we will evaluate the implementation strategy using a cost-effectiveness analysis.Discussion: This is the first project in a Latin-American setting to implement a salt substitution intervention at the population level to tackle high blood pressure. Data generated and lessons learnt from this study will provide a strong platform to address potential interventions applicable to other similar low- and middle-income settings.Trial registration: This study is registered in ClinicalTrials.gov NCT01960972.

Funding Details

This study is supported by the National Heart, Lung, and Blood Institute (Project 1 U01 HL114180-01), United States, under The Global Alliance for Chronic Diseases (GACD) programme. All authors and the CRONICAS Center of Excellence in Chronic Diseases are supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases (Project Number 268200900033C-1-0-1).
FundersFunding numbers
National Heart, Lung, and Blood Institute
-
NHLBI
268200900033C-1-0-1, U01HL114180

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
128
Mentions
4
Citations
32
Social media
34